Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS DEVON INTEGRATED CARE BOARD
QJK
Aperture House, Pynes Hill, Rydon Lane,
Exeter
EX25AZ
UK
Contact person: Tracey Kerslake
Telephone: +44 1392205205
E-mail: d-icb.contracting@nhs.net
NUTS: UKK4
Internet address(es)
Main address: https://devon.icb.nhs.uk/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Antipsychotic Medication Reviews
Reference number: QJK-24_APMR
II.1.2) Main CPV code
85121270
II.1.3) Type of contract
Services
II.1.4) Short description
Provision of an antipsychotic prescribing and drug safety monitoring service for patients registered with a GP in Devon
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
.01
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKK4
II.2.4) Description of the procurement
The primary aim of this service is to provide ongoing prescribing of antipsychotic medications and drug safety monitoring for patients across NHS Devon with an initial requirement for up to 120 patients. The provider will:
• Ensure ongoing drug safety monitoring and prescribing including appropriate blood tests and ECGs and informed by NICE guidelines
• Ensure that any concerns related to the person's mental health are appropriately escalated to the secondary mental health provider.
• Issue prescription that will be dispended by the patient's local pharmacy.
It is anticipated that after an initial review, 1-2 months prescription lengths would be required, with a 12 month annual review. However, the provider must use clinical judgement, informed by NICE guidance, to determine the physical health monitoring needs of the individual and safe length of prescription.
The ICB envisages care being delivered as close to home as possible, however this could include the service being delivered remotely, with the preferred remote method of contact being agreed with the patient. Where the service is delivered remotely it is anticipated that the primary method will be via Teams (or an equivalent system for safe virtual delivery) and the provider will take reasonable steps to support the patient in the utilisation of IT where advice and guidance may be required e.g. easy to read, jargon free instructions. Should digital poverty or IT connectivity prevent use of virtual delivery, the provider needs to have mitigations available.
This notice is an intention to award a contract under the Provider Selection Regime Most Suitable Provider process.
This is a new service and the award is to an existing contracted provider
The contract term is for a period 12 months. The cost of the service will be based on activity with an anticipated annual cost of approximately £945 per patient where a face to face consultation is required and £645 per patient where a virtual consultation is undertaken. There maybe additional costs payable for diagnostic tests
II.2.5) Award criteria
Quality criterion: Most suitable provider process with regard to the key criteria
/ Weighting: 80
Cost criterion: Most suitable provider process with regard to price
/ Weighting: 20
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The publication of this notice marks the start of the standstill period.
Representations by providers must be made to the relevant authority by 23 October 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.'
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section V: Award of contract
Contract No: QJK-25_APMR
Title: Antipsychotic Medication Reviews
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
13/10/2025
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
RTN Medical Limited
14100590
167-169 Great Portland Street, 5th Floor,
Londong
W1W 5PF
UK
NUTS: UKI
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: .01
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 23 October 2025. This contract has not yet been formally awarded; this notice serves as an intention to award under PSR.
Notices previously published on Find A Tender in relation to this award:
2025/S 000-052253 29 August 2025
2025/S 000-047397 08 August 2025
VI.4) Procedures for review
VI.4.1) Review body
NHS Devon ICB
Aperture House, Pynes Hill, Rydon Lane,
Exeter
EX2 5AZ
UK
E-mail: d-icb.contracting@nhs.net
Internet address(es)
URL: https://devon.icb.nhs.uk/
VI.5) Date of dispatch of this notice
13/10/2025